Bridgewater Associates LP Lowers Stake in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)
Bridgewater Associates LP decreased its position in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 12.5% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 11,962 shares of the biopharmaceutical company’s stock after selling 1,706 shares during the quarter. Bridgewater Associates LP’s holdings in Ultragenyx Pharmaceutical were worth $552,000 at the end […]
More Stories
Democrats Sue Trump Admin Over Bid to Clean Up Voter Rolls
By Zachary Stieber Senate Minority Leader Chuck Schumer (D-N.Y.) and other Democrats have sued the Trump administration over its effort...
Implementing Freight Management Software: In-House or With Specialist Help?
You’ve picked a freight platform. Now you have to get it live without stopping trucks, missing invoices or losing track...
DOGE Illegally Accessed Data on Government Workers: Judge
By Zachary Stieber A federal judge ruled on Oct. 20 that a department aimed at making the government more efficient...
UK Rearrests 2 Men Over Suspected Terror Plot at Air Base
By Jill McLaughlin UK police have rearrested two men, suspected of working for Iran’s intelligence service, for allegedly plotting to...
$245 Million Taxpayer-Backed Loan to Fund Naval Shipbuilding Facilities
By AAP Australia will lend hundreds of millions of dollars to the nation’s largest shipbuilder for a massive new manufacturing...
Music Publishers Sue Anthropic for Copyright Infringement
By Stacy Robinson A federal district court in California is set to hear arguments this week as a group of...